These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 24309604

  • 1. Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.
    Wang Z, Li K, Dong K, Xiao X, Zheng S.
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):72-3. PubMed ID: 24309604
    [No Abstract] [Full Text] [Related]

  • 2. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
    Chan S, Cassarino DS.
    JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
    [No Abstract] [Full Text] [Related]

  • 3. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H, Guo X, Duan Y, Zheng B, Gao Y.
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [Abstract] [Full Text] [Related]

  • 4. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y, Kong L, Sun B, Cui J, Shen W.
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [Abstract] [Full Text] [Related]

  • 5. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W, Li K, Wang Z, Dong K, Zheng S.
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [Abstract] [Full Text] [Related]

  • 6. Expansile kaposiform hemangioendothelioma deformed thoracic cage in an adult.
    Wu CH, Tsai TM, Liau JY, Chang YL, Lai HS, Lee JM.
    Ann Thorac Surg; 2013 Nov; 96(5):1854-7. PubMed ID: 24182473
    [Abstract] [Full Text] [Related]

  • 7. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG, Schmitt IR, Garcia CD, Kiszewski AE.
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y, Chen S, Xiang B, Li K, Xu Z, Yao W, Lu G, Liu X, Xia C, Wang Q, Li Y, Wang C, Yang K, Yang G, Tang X, Xu T, Wu H.
    Int J Cancer; 2017 Aug 15; 141(4):848-855. PubMed ID: 28486787
    [Abstract] [Full Text] [Related]

  • 11. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J, Lackner H, Reiterer F, Urlesberger B, Urban C.
    Klin Padiatr; 2012 Oct 15; 224(6):395-7. PubMed ID: 23070861
    [No Abstract] [Full Text] [Related]

  • 12. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J, Smink GM, Helm K, Xavier F.
    Pediatr Blood Cancer; 2018 Dec 15; 65(12):e27305. PubMed ID: 30070028
    [Abstract] [Full Text] [Related]

  • 13. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H, Ozeki M, Hori T, Kanda K, Kawamoto N, Nagano A, Azuma E, Miyazaki T, Fukao T.
    J Pediatr Hematol Oncol; 2016 Nov 15; 38(8):e322-e325. PubMed ID: 26907642
    [Abstract] [Full Text] [Related]

  • 14. Association between extremity kaposiform hemangioendothelioma and lymphedema.
    Konczyk DJ, Goss JA, Maclellan RA, Greene AK.
    Pediatr Dermatol; 2018 Jan 15; 35(1):e92-e93. PubMed ID: 29266383
    [Abstract] [Full Text] [Related]

  • 15. [Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon].
    Inguanzo-Ortiz M, Piqué-Duran E, Aparicio-Sánchez JL, Vaca-Arellano MR.
    An Pediatr (Engl Ed); 2018 May 15; 88(5):292-293. PubMed ID: 29625805
    [No Abstract] [Full Text] [Related]

  • 16. Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies.
    Fuchimoto Y, Morikawa N, Kuroda T, Hirobe S, Kamagata S, Kumagai M, Matsuoka K, Morikawa Y.
    Pediatr Int; 2012 Apr 15; 54(2):285-7. PubMed ID: 22507155
    [No Abstract] [Full Text] [Related]

  • 17. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
    Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L, Mariani G.
    J Vasc Interv Radiol; 2012 Mar 15; 23(3):417-22. PubMed ID: 22365299
    [Abstract] [Full Text] [Related]

  • 18. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y, Chen S, Yang K, Xia C, Peng S.
    J Dermatol; 2018 Oct 15; 45(10):1203-1206. PubMed ID: 30118141
    [Abstract] [Full Text] [Related]

  • 19. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
    Benzar IM, Rebenkov SO, Levytskyi AF, Fedoniuk LY, Fomina LV, Sas LM, Stravskyy TY.
    Wiad Lek; 2020 Oct 15; 73(8):1785-1789. PubMed ID: 33055352
    [Abstract] [Full Text] [Related]

  • 20. Kaposiform Hemangioendothelioma: Multifocal Involvement, Chylothorax, and Kasabach-Merritt Phenomenon.
    Das A, Bansal D, Chatterjee D, Das A.
    J Pediatr Hematol Oncol; 2017 Mar 15; 39(2):153-154. PubMed ID: 27820128
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.